Results 1 to 10 of about 67,813 (323)

Epidemiology and risk factors for phantom limb pain [PDF]

open access: yesFrontiers in Pain Research
Approximately 356 million limb amputations are performed globally every year. In 2005, the prevalence of limb loss in the United States was 1.6 million people; and it is estimated to increase to 3.6 million by 2050.
Shoji Ishigami   +2 more
doaj   +3 more sources

Risk Factors Analysis of Phantom Limb Pain in Amputees with Malignant Tumors [PDF]

open access: yesJournal of Pain Research, 2023
Xiulin Huo,1,2 Peiying Huang,1 Hexuan Di,3 Tianxiao Ma,3 Sufang Jiang,1 Jie Yao,4 Lining Huang1 1Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China; 2Department of Anesthesiology,
Huo X   +6 more
doaj   +3 more sources

An Algorithm Approach to Phantom Limb Pain [PDF]

open access: yesJournal of Pain Research, 2022
Jacob Boomgaardt,1 Kovosh Dastan,1 Tiffany Chan,2 Ashley Shilling,2 Alaa Abd-Elsayed,3 Lynn Kohan2 1Department of Physical Medicine and Rehabilitation, University of Virginia, Charlottesville, VA, USA; 2Department of Anesthesiology, University of ...
Boomgaardt J   +5 more
doaj   +3 more sources

Managing acute phantom limb pain with transcutaneous electrical nerve stimulation: a case report

open access: yesJournal of Medical Case Reports, 2023
Introduction Phantom limb pain is characterized by painful sensations in the amputated limb. The clinical presentation of acute phantom limb pain may differ from that of patients with chronic phantom limb pain.
Katleho Limakatso
doaj   +2 more sources

Calcitonin in the Treatment of Phantom Limb Pain: A Systematic Review. [PDF]

open access: yesCNS Drugs, 2023
Introduction Phantom limb pain (PLP) refers to pain perceived in a part of the body removed by amputation or trauma. Despite the high prevalence of PLP following amputation and the significant morbidity associated with it, robust therapeutic approaches ...
Neumüller J   +4 more
europepmc   +2 more sources

Patient-centered results from a multicenter study of continuous peripheral nerve blocks and postamputation phantom and residual limb pain: secondary outcomes from a randomized, clinical trial [PDF]

open access: hybridRegional anesthesia and pain medicine, 2023
Introduction We previously reported that a 6-day continuous peripheral nerve block reduces established postamputation phantom pain. To provide patients and providers with the information to best inform treatment decisions, here we reanalyze the data and ...
Brian M. Ilfeld   +13 more
openalex   +2 more sources

Characteristics of phantom limb pain in U.S. civilians and service members [PDF]

open access: greenScandinavian Journal of Pain, 2021
Objectives The population of Americans with limb loss is on the rise, with a different profile than in previous generations (e.g., greater incidence of amputation due to diabetes).
Sarah C. Griffin   +10 more
openalex   +2 more sources

The prevalence and risk factors for phantom limb pain: a cross-sectional survey. [PDF]

open access: yesBMC Neurol
We previously performed a systematic review and meta-analysis which revealed a Phantom Limb Pain (PLP) prevalence estimate of 64% [95% CI: 60.01–68.1]. The prevalence estimates varied significantly between developed and developing countries.
Limakatso K   +5 more
europepmc   +2 more sources

Extended reality used in the treatment of phantom limb pain: a multicenter, double-blind, randomized controlled trial. [PDF]

open access: yesPain
Supplemental Digital Content is Available in the Text. The use of phantom motor execution and phantom motor imagery aided by extended reality substantially alleviates phantom limb pain and its associated comorbidities.
Lendaro E   +19 more
europepmc   +2 more sources

Central nervous system stimulation therapies in phantom limb pain: a systematic review of clinical trials

open access: yesNeural Regeneration Research, 2022
Phantom limb pain is a chronic pain syndrome that is difficult to cope with. Despite neurostimulation treatment is indicated for refractory neuropathic pain, there is scant evidence from randomized controlled trials to recommend it as the treatment ...
M Ángeles Garcia-Pallero   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy